Healthcare stocks aren’t known for producing mind-blowing dividends, but the sector is home to a budding biotechnology and biopharmaceutical industry. Despite underlying volatility in biotech plays, innovative companies with strong drug candidate pipelines continue delivering value – and dividends to their shareholders. Our latest addition to the Best Healthcare Dividend Stocks List is a biotechnology company with a 10+ year track record of dividend growth. Investors have until Wednesday, May 17, to capitalize on the strategy to earn a regular dividend payout of $2.13 a share.
You can check out the Best Healthcare Dividend Stocks List to explore all the stocks.
Thanks to its well-balanced portfolio of leading drugs, growing sales volumes and a steady pipeline of new treatments, our pick provides plenty of potential upside. 2022 was a solid year for our pick. While revenues and earnings didn’t grow significantly, the company achieved all of its major targets.
To make room for our biotech play, we had to swap out another biopharmaceutical play due to limited upside potential.
